Our findings demonstrate that ZXYF alleviates lipid metabolic abnormalities in AS mice by restoring bile acid enterohepatic circulation via the FXR/FGF15 pathway, highlighting its therapeutic potential for metabolic disorders. The gene discussed is NR1H4; the disease is metabolic disease.